| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |